Turn Therapeutics Inc. (TTRX) Financials
TTRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 17.0 million | 16.3 million |
| March 31, 2026 | 18.6 million | 12.5 million |
| Dec. 31, 2025 | 12.2 million | 7.5 million |
| Sept. 30, 2025 | 4.4 million | 3.8 million |
TTRX Free Cash Flow and Stock based compensation
No data available :(
TTRX Net Income
No data available :(
TTRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 10.3 million | 6.1 million | 8713 |
| March 31, 2026 | 11.2 million | 5.9 million | 21539 |
| Dec. 31, 2025 | 5.1 million | - | 80376 |
| Sept. 30, 2025 | 3.1 million | - | 46344 |
TTRX Shares Outstanding
TTRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4 | 475064 | 1.1 million | - |
| March 31, 2026 | 3 | 109434 | 1.1 million | - |
| Dec. 31, 2025 | 3 | 34934 | 2.1 million | - |
| Sept. 30, 2025 | - | 158699 | 1.7 million | - |
TTRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 14531 |
| March 31, 2026 | - | 14451 |
| Dec. 31, 2025 | - | 14155 |
| Sept. 30, 2025 | - | 13679 |
TTRX
Price: $9.90
52 week price:
Earnings Per Share: -0.28 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 285.1 million